Detalhe da pesquisa
1.
Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.
Int Wound J
; 6(1): 67-72, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19291119
2.
Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
Int Wound J
; 4(4): 333-43, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17953679
3.
Scaling-up fermentation of Escherichia coli for production of recombinant P64k protein from Neisseria meningitidis
Electron. j. biotechnol
; 33: 29-35, May. 2018. tab, graf, ilus
Artigo
em Inglês
| LILACS | ID: biblio-1022834